FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KDM2A-CCDC170

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KDM2A-CCDC170
FusionPDB ID: 41711
FusionGDB2.0 ID: 41711
HgeneTgene
Gene symbol

KDM2A

CCDC170

Gene ID

22992

80129

Gene namelysine demethylase 2Acoiled-coil domain containing 170
SynonymsCXXC8|FBL11|FBL7|FBXL11|JHDM1A|LILINAC6orf97|bA282P11.1
Cytomap

11q13.2

6q25.1

Type of geneprotein-codingprotein-coding
Descriptionlysine-specific demethylase 2ACXXC-type zinc finger protein 8F-box and leucine-rich repeat protein 11F-box/LRR-repeat protein 11[Histone-H3]-lysine-36 demethylase 1AjmjC domain-containing histone demethylation protein 1Ajumonji C domain-containing hcoiled-coil domain-containing protein 170
Modification date2020032020200313
UniProtAcc

Q9Y2K7

Main function of 5'-partner protein: FUNCTION: Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis. Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-ARNTL/BMAL1 heterodimer and RORA in a catalytically-independent manner (PubMed:26037310). {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:19001877, ECO:0000269|PubMed:26037310, ECO:0000269|PubMed:28262558}.

Q8IYT3

Main function of 5'-partner protein: FUNCTION: Plays a role in Golgi-associated microtubules organization and stabilization. {ECO:0000269|PubMed:28687497}.
Ensembl transtripts involved in fusion geneENST idsENST00000398645, ENST00000529006, 
ENST00000308783, ENST00000526258, 
ENST00000530342, 
ENST00000544131, 
ENST00000239374, ENST00000367290, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score36 X 24 X 17=146887 X 13 X 7=637
# samples 5020
** MAII scorelog2(50/14688*10)=-4.87656605875172
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(20/637*10)=-1.67129337248158
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KDM2A [Title/Abstract] AND CCDC170 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KDM2A [Title/Abstract] AND CCDC170 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KDM2A(66888829)-CCDC170(151936578), # samples:2
Anticipated loss of major functional domain due to fusion event.KDM2A-CCDC170 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM2A-CCDC170 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:66888829/chr6:151936578)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KDM2A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CCDC170 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000398645KDM2Achr1166888829+ENST00000239374CCDC170chr6151936578+439090662633197
ENST00000398645KDM2Achr1166888829+ENST00000367290CCDC170chr6151936578+439090662633197
ENST00000529006KDM2Achr1166888829+ENST00000239374CCDC170chr6151936578+3972488446925159
ENST00000529006KDM2Achr1166888829+ENST00000367290CCDC170chr6151936578+3972488446925159

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000398645ENST00000239374KDM2Achr1166888829+CCDC170chr6151936578+0.0041980540.995802
ENST00000398645ENST00000367290KDM2Achr1166888829+CCDC170chr6151936578+0.0041980540.995802
ENST00000529006ENST00000239374KDM2Achr1166888829+CCDC170chr6151936578+0.0044420530.99555796
ENST00000529006ENST00000367290KDM2Achr1166888829+CCDC170chr6151936578+0.0044420530.99555796

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KDM2A-CCDC170

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KDM2Achr1166888829CCDC170chr615193657848814EPEEERIRYSQRLIKTLEQTKAIEDL

Top

Potential FusionNeoAntigen Information of KDM2A-CCDC170 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-CCDC170_66888829_151936578.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B14:02SQRLIKTL0.99890.5026917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B14:01SQRLIKTL0.99890.5026917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B52:01SQRLIKTL0.82950.7338917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:05IRYSQRLIK0.99910.8181615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:17YSQRLIKTL0.99390.8787817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:04IRYSQRLIK0.99160.5696615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:16YSQRLIKTL0.9880.5394817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B57:03YSQRLIKTL0.98760.9387817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:08RIRYSQRLI0.97250.6201514
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:08RIRYSQRLIK0.99790.5623515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:05RIRYSQRLIK0.98120.7746515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:08RLIKTLEQTK0.97680.85221121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A74:03RLIKTLEQTK0.85480.56591121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A74:09RLIKTLEQTK0.85480.56591121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A74:11RLIKTLEQTK0.85480.56591121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:04RIRYSQRLIK0.83270.5833515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:04IRYSQRLIKTL10.646617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:05IRYSQRLIKTL10.8344617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:02IRYSQRLIKTL10.5199617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:05QRLIKTLEQTK0.99990.73591021
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:07SQRLIKTL0.99850.7591917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:04SQRLIKTL0.99560.9444917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B14:03SQRLIKTL0.95570.6642917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C15:04YSQRLIKTL0.99970.7948817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:08YSQRLIKTL0.99960.8859817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C15:06YSQRLIKTL0.99920.8241817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:07YSQRLIKTL0.99890.9488817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:19YSQRLIKTL0.99890.982817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C12:12YSQRLIKTL0.99690.8807817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:14IRYSQRLIK0.99630.658615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:03YSQRLIKTL0.99630.9913817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C12:04YSQRLIKTL0.99590.9947817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C08:04YSQRLIKTL0.99480.9586817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C08:13YSQRLIKTL0.99480.9586817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C01:17YSQRLIKTL0.9860.9517817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:14YSQRLIKTL0.98250.9674817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:03IRYSQRLIK0.97460.8361615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C08:03YSQRLIKTL0.95390.9734817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C02:06YSQRLIKTL0.92730.9716817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C01:30YSQRLIKTL0.90820.9706817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:14RIRYSQRLIK0.96130.713515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:03RIRYSQRLIK0.7450.7959515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:14IRYSQRLIKTL10.755617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:14QRLIKTLEQTK0.99980.71091021
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C07:05IRYSQRLIKTL0.99940.9151617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:03IRYSQRLIKTL0.99920.8568617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:35SQRLIKTL0.99830.9058917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:68SQRLIKTL0.98560.7011917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:73SQRLIKTL0.9830.7784917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:08IRYSQRLI0.98090.9388614
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B15:30SQRLIKTL0.96920.8208917
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:17IRYSQRLI0.93230.9661614
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:02IRYSQRLI0.93230.9661614
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C15:09YSQRLIKTL0.99970.7948817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:04YSQRLIKTL0.99950.9874817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:03YSQRLIKTL0.99950.9874817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:05YSQRLIKTL0.99920.9369817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:02YSQRLIKTL0.99880.964817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C16:04YSQRLIKTL0.99880.9625817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C15:05YSQRLIKTL0.99870.8496817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:10IRYSQRLIK0.99870.7327615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:17YSQRLIKTL0.99860.9751817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:67YSQRLIKTL0.99860.9705817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C15:02YSQRLIKTL0.99830.7725817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:08IRYSQRLIK0.99810.6612615
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C12:03YSQRLIKTL0.99760.9767817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C12:02YSQRLIKTL0.99580.9667817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:06YSQRLIKTL0.99350.9917817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:17YSQRLIKTL0.99220.9939817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:02YSQRLIKTL0.99220.9939817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C03:06YSQRLIKTL0.99170.986817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B58:06YSQRLIKTL0.98950.6768817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C01:02YSQRLIKTL0.98790.9514817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C16:02YSQRLIKTL0.98490.9883817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C16:01YSQRLIKTL0.98430.976817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:01RIRYSQRLI0.97740.7741514
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C08:01YSQRLIKTL0.95390.9734817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C02:02YSQRLIKTL0.95140.9829817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C02:10YSQRLIKTL0.95140.9829817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C06:08YSQRLIKTL0.9440.9924817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-C17:01YSQRLIKTL0.8680.8454817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B57:02YSQRLIKTL0.83330.6948817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B07:13YSQRLIKTL0.52860.7384817
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:01RIRYSQRLIK0.9980.7446515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A30:01RLIKTLEQTK0.97720.92911121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:10RIRYSQRLIK0.95510.7455515
KDM2A-CCDC170chr1166888829chr6151936578488HLA-A74:01RLIKTLEQTK0.85480.56591121
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:08IRYSQRLIKTL10.7236617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:09IRYSQRLIKTL10.7824617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:10IRYSQRLIKTL10.7849617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:06IRYSQRLIKTL10.6222617
KDM2A-CCDC170chr1166888829chr6151936578488HLA-B27:10QRLIKTLEQTK0.99990.80381021

Top

Potential FusionNeoAntigen Information of KDM2A-CCDC170 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM2A-CCDC170_66888829_151936578.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1102EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1103EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1113EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1116EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1121EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1136EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1148EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1159EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1163EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1165EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1176EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1185EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1186EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1201QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1203QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1204QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1204SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1205QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1206QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1207QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1209QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1209SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1210QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1211QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1212QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1213QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1213SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1214QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1215QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1215SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1217QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1218QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1218SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1219QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1219SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1220QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1220SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1221QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1221SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1223QRLIKTLEQTKAIED1025
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1223SQRLIKTLEQTKAIE924
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1301EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1308EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1315EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1316EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1319EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1319EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1320EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1322EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1324EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1327EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1327EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1327PEEERIRYSQRLIKT116
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1335EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1341EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1351EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1352EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1353EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1353EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1357EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1359EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1361EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1361EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1364EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1368EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1369EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1370EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1371EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1371EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1371PEEERIRYSQRLIKT116
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1372EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1376EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1376EEERIRYSQRLIKTL217
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1376PEEERIRYSQRLIKT116
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1378EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1379EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1380EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1383EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1384EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1387EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1391EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1392EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1396EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1398EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1433EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1464EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1472EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1495EERIRYSQRLIKTLE318
KDM2A-CCDC170chr1166888829chr6151936578488DRB1-1495EEERIRYSQRLIKTL217

Top

Fusion breakpoint peptide structures of KDM2A-CCDC170

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3968IRYSQRLIKTLEQTKDM2ACCDC170chr1166888829chr6151936578488

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KDM2A-CCDC170

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3968IRYSQRLIKTLEQT-7.9962-8.1096
HLA-B14:023BVN3968IRYSQRLIKTLEQT-5.70842-6.74372
HLA-B52:013W393968IRYSQRLIKTLEQT-6.83737-6.95077
HLA-B52:013W393968IRYSQRLIKTLEQT-4.4836-5.5189
HLA-A11:014UQ23968IRYSQRLIKTLEQT-10.0067-10.1201
HLA-A11:014UQ23968IRYSQRLIKTLEQT-9.03915-10.0745
HLA-A24:025HGA3968IRYSQRLIKTLEQT-6.56204-6.67544
HLA-A24:025HGA3968IRYSQRLIKTLEQT-5.42271-6.45801
HLA-B44:053DX83968IRYSQRLIKTLEQT-7.85648-8.89178
HLA-B44:053DX83968IRYSQRLIKTLEQT-5.3978-5.5112
HLA-A02:016TDR3968IRYSQRLIKTLEQT-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of KDM2A-CCDC170

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KDM2A-CCDC170chr1166888829chr61519365781021QRLIKTLEQTKCAGAGATTGATTAAAACTTTGGAACAGACTAAA
KDM2A-CCDC170chr1166888829chr61519365781121RLIKTLEQTKAGATTGATTAAAACTTTGGAACAGACTAAA
KDM2A-CCDC170chr1166888829chr6151936578514RIRYSQRLIAGGATTCGTTACAGCCAGAGATTGATT
KDM2A-CCDC170chr1166888829chr6151936578515RIRYSQRLIKAGGATTCGTTACAGCCAGAGATTGATTAAA
KDM2A-CCDC170chr1166888829chr6151936578614IRYSQRLIATTCGTTACAGCCAGAGATTGATT
KDM2A-CCDC170chr1166888829chr6151936578615IRYSQRLIKATTCGTTACAGCCAGAGATTGATTAAA
KDM2A-CCDC170chr1166888829chr6151936578617IRYSQRLIKTLATTCGTTACAGCCAGAGATTGATTAAAACTTTG
KDM2A-CCDC170chr1166888829chr6151936578817YSQRLIKTLTACAGCCAGAGATTGATTAAAACTTTG
KDM2A-CCDC170chr1166888829chr6151936578917SQRLIKTLAGCCAGAGATTGATTAAAACTTTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KDM2A-CCDC170chr1166888829chr6151936578116PEEERIRYSQRLIKTCCCGAAGAAGAAAGGATTCGTTACAGCCAGAGATTGATTAAAACT
KDM2A-CCDC170chr1166888829chr61519365781025QRLIKTLEQTKAIEDCAGAGATTGATTAAAACTTTGGAACAGACTAAAGCCATTGAAGAT
KDM2A-CCDC170chr1166888829chr6151936578217EEERIRYSQRLIKTLGAAGAAGAAAGGATTCGTTACAGCCAGAGATTGATTAAAACTTTG
KDM2A-CCDC170chr1166888829chr6151936578318EERIRYSQRLIKTLEGAAGAAAGGATTCGTTACAGCCAGAGATTGATTAAAACTTTGGAA
KDM2A-CCDC170chr1166888829chr6151936578924SQRLIKTLEQTKAIEAGCCAGAGATTGATTAAAACTTTGGAACAGACTAAAGCCATTGAA

Top

Information of the samples that have these potential fusion neoantigens of KDM2A-CCDC170

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAKDM2A-CCDC170chr1166888829ENST00000529006chr6151936578ENST00000239374TCGA-A8-A081-01A

Top

Potential target of CAR-T therapy development for KDM2A-CCDC170

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KDM2A-CCDC170

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KDM2A-CCDC170

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource